Shannon Craft
Psychiatric/Mental Health · Portsmouth, RINPI 1174875132
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 163 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 14.0% — the pattern of someone who eats at a lot of different presentations. Among psychiatric/mental health clinicians in RI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 163 payments — averaging $31.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$707
- Corium, LLC$622
- Neurocrine Biosciences, Inc.$587
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$538
- Axsome Therapeutics, Inc.$530
- Alkermes, Inc.$245
- plus $2K from 17 others
What the payments were for
- Food & beverage$5,055100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 27 | $707 |
| Corium, LLC | 32 | $622 |
| Neurocrine Biosciences, Inc. | 14 | $587 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 13 | $538 |
| Axsome Therapeutics, Inc. | 13 | $530 |
| Alkermes, Inc. | 8 | $245 |
| Johnson & Johnson | 7 | $239 |
| Otsuka America Pharmaceutical, Inc. | 7 | $236 |
| Teva Pharmaceuticals USA, Inc. | 6 | $227 |
| Vanda Pharmaceuticals Inc. | 6 | $226 |
| Ironshore Pharmaceuticals Inc. | 6 | $167 |
| Supernus Pharmaceuticals, Inc. | 7 | $135 |
| Jazz Pharmaceuticals Inc. | 1 | $113 |
| E.r. Squibb & Sons, L.L.C. | 2 | $106 |
| Idorsia Pharmaceuticals US Inc | 2 | $102 |
| Biogen | 2 | $100 |
| Lundbeck LLC | 4 | $59 |
| Gilead | 1 | $31 |
| Sage Therapeutics, LLC | 1 | $19 |
| Vertical Pharmaceuticals, LLC | 1 | $18 |
| Pear Therapeutics (US), Inc. | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| Collegium Pharmaceutical, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,055 in reported general payments places this provider in the 90th percentile of 196 psychiatric/mental health providers in Rhode Island.
See all psychiatric/mental health providers in Rhode Island →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 26 | $930 |
| Lithium Carbonate ErLithium Carbonate | 20 | $437 |
| Aripiprazole | 14 | $155 |
| Clonidine Hcl | 13 | $136 |
| Topiramate | 12 | $40 |
| Lorazepam | 20 | $29 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Portsmouth
- Sarah Buck HerdrichPortsmouth$5K
- Rebecca ParantPortsmouth$2K
- Samantha Shawn MarshBradford$639K
- Samuel KaufmanRiverside$19K
- Katie ThayerWarwick$16K
- Arielle RoundsWarwick$15K
- Eniayo EgberongbeCranston$12K
- Deborah HorvitzWarwick$10K
- Donna McDonaldProvidence$9K
- Timothy PepinNorth Smithfield$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.